Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
129 studies found for:    Empagliflozin
Show Display Options
Rank Status Study
1 Not yet recruiting Empagliflozin Impact on Hemodynamics in Patients With Diabetes and Heart Failure
Condition: Heart Failure
Interventions: Drug: Empagliflozin 10Mg Tab;   Drug: Placebo Oral Tablet
2 Recruiting Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Condition: Non Alcoholic Fatty Liver Disease
Intervention: Drug: Empagliflozin
3 Recruiting Empagliflozin in Post-Transplantation Diabetes Mellitus
Condition: Posttransplant Diabetes Mellitus
Intervention: Drug: Empagliflozin 10 mg
4 Completed Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin;   Drug: Placebo
5 Recruiting Empagliflozin and Renal Oxygenation in Healthy Volunteers
Condition: Nephropathy
Interventions: Drug: Empagliflozin 10 mg;   Drug: Placebo
6 Recruiting Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
Conditions: Diabetes Mellitus, Type 2;   Diastolic Dysfunction
Interventions: Drug: Empagliflozin;   Drug: Placebo
7 Recruiting Effects of Empagliflozin + Linagliptin vs Metformin + Insulin Glargine on Renal and Vascular Changes in Type 2 Diabetes
Condition: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin and Linagliptin;   Drug: Metformin and Insulin sc
8 Completed Pharmacokinetic Evaluation of Empagliflozin
Condition: Diabetes Mellitus
Intervention: Drug: Empagliflozin 25mg
9 Not yet recruiting Empagliflozin vs Metformin in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Empagliflozin;   Drug: Metformin
10 Recruiting Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes
Conditions: Diabetes;   Cardiovascular Disease
Interventions: Drug: Empagliflozin;   Drug: Placebo
11 Completed Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Linagliptin;   Other: Placebo;   Drug: Empagliflozin
12 Not yet recruiting Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
Condition: Acute Myocardial Infarction
Interventions: Drug: Empagliflozin 10 mg;   Drug: Placebo Oral Tablet
13 Recruiting Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes;   Non-alcoholic Fatty Liver Disease
Interventions: Drug: Empagliflozin;   Drug: Placebo
14 Recruiting Empagliflozin and ACEi Effects on Hyperfiltration in Type 1 Diabetes (BETWEEN Study)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Empagliflozin;   Drug: Placebo (matching empagliflozin);   Drug: ramipril
15 Not yet recruiting EMPRA (EMPagliflozin and RAs in Kidney Disease)
Conditions: Diabetic Kidney Disease;   Diabetes Mellitus, Type 2;   Chronic Kidney Disease stage3;   Chronic Kidney Disease stage4
Interventions: Drug: Empagliflozin 10 MG [Jardiance];   Drug: Placebo Oral Tablet
16 Not yet recruiting The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes
Conditions: Type2 Diabetes;   NAFLD
Intervention: Drug: Empagliflozin
17 Completed Empa/Lina FDC Food Effect Study (Japan)
Condition: Healthy
Intervention: Drug: empagliflozin/linagliptin FDC
18 Completed
Has Results
Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition: Healthy
Interventions: Drug: Empagliflozin;   Drug: Metformin
19 Not yet recruiting Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
Conditions: Heart Failure;   Type II; Diabetes
Interventions: Drug: Empagliflozin;   Drug: Placebo Oral Capsule
20 Not yet recruiting Double Blind Placebo Study of JARDIANCE® (Empagliflozin) in Prehypertensives Type II Diabetics
Conditions: Hypertension;   Type II Diabetes
Interventions: Drug: empagliflozin;   Drug: Metformin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.